Comparative Studies on the Radioimmunological Determination of Carcinoembryonic Antigen in Tumour Tissue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Erschienen in
-
In: Clinical Chemistry and Laboratory Medicine, Band 16, Ausgabe 6, Seite 323-328, 2009
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
1978
- Urheber
-
Wagener, C.
BREUER, H.
- DOI
-
10.18452/12501
- URN
-
urn:nbn:de:kobv:11-100159591
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wagener, C.
- BREUER, H.
- Humboldt-Universität zu Berlin
Entstanden
- 1978
Ähnliche Objekte (12)
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Comparison of Cytokeratin Fragment 19 (CYFRA 21-1), Tissue Polypeptide Antigen (TPA) and Tissue Polypeptide Specific Antigen (TPS) as Tumour Markers in Lung Cancer
Placental Alkaline Phosphatase in Tumour Tissue and Serum
HNSCC: tumour antigens and their targeting by immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Hibernoma – two patients with a rare lipoid soft-tissue tumour
Tissue Polypeptide Antigen and Tissue Polypeptide Specific Antigen in Primary Breast Cancer. Evaluation in Serum and Tutmour Tissue
Chromosomal clustering of tissue restricted antigens
Untersuchungen zum "Tissue Polypeptide Antigen" (TPA)
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
New tumour associated antigens : 2 years clin. experience with monoclonal antibodies
Die Freisetzung der Tumormarker Tissue Polypeptide Antigen (TPA) und Specific Tissue Polypeptide Antigen (TPS) aus Tumorzellen
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Comparison of Cytokeratin Fragment 19 (CYFRA 21-1), Tissue Polypeptide Antigen (TPA) and Tissue Polypeptide Specific Antigen (TPS) as Tumour Markers in Lung Cancer
Placental Alkaline Phosphatase in Tumour Tissue and Serum
HNSCC: tumour antigens and their targeting by immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Hibernoma – two patients with a rare lipoid soft-tissue tumour
Tissue Polypeptide Antigen and Tissue Polypeptide Specific Antigen in Primary Breast Cancer. Evaluation in Serum and Tutmour Tissue
Chromosomal clustering of tissue restricted antigens
Untersuchungen zum "Tissue Polypeptide Antigen" (TPA)
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
New tumour associated antigens : 2 years clin. experience with monoclonal antibodies
Die Freisetzung der Tumormarker Tissue Polypeptide Antigen (TPA) und Specific Tissue Polypeptide Antigen (TPS) aus Tumorzellen
Limited Improvement of Tumour Diagnosis by the Simultaneous Determination of Carcinoembryonic Antigen (CEA) and of a Tumour-Associated CEA-Related Antigen of Mr 128000 in Serum
Comparison of Cytokeratin Fragment 19 (CYFRA 21-1), Tissue Polypeptide Antigen (TPA) and Tissue Polypeptide Specific Antigen (TPS) as Tumour Markers in Lung Cancer
Placental Alkaline Phosphatase in Tumour Tissue and Serum
HNSCC: tumour antigens and their targeting by immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Hibernoma – two patients with a rare lipoid soft-tissue tumour
Tissue Polypeptide Antigen and Tissue Polypeptide Specific Antigen in Primary Breast Cancer. Evaluation in Serum and Tutmour Tissue
Chromosomal clustering of tissue restricted antigens
Untersuchungen zum "Tissue Polypeptide Antigen" (TPA)
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
New tumour associated antigens : 2 years clin. experience with monoclonal antibodies